Roche provides an update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer

    NEXT STORY
    ERYTECH Announces a Poster Presentation for TRYbeCA1 at the ASCO 2020
    PREV STORY
    The lancets market is projected to reach USD 1,442 million by 2024 from USD 804 million in 2019, at a CAGR of 12.4%
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Konica Minolta’s Exa Platform Helps Green Bay Radiology Grow While Streamlining Operations

    WAYNE, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. announces ...

    author_avatar
    NASDAQ Market News

    Bavarian Nordic meddeler at Janssen har modtaget positiv anbefaling fra det Europæiske Lægemiddelagentur vedrørende godkendelse af ebolavaccinen

    author_avatar
    NASDAQ Market News

    PolarityTE™ Announces Application of SkinTE™ on First Patients

    SALT LAKE CITY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ:COOL) announced that ...

    author_avatar
    NASDAQ Market News